The present invention relates to the treatment of wounds. More particularly, it relates to compounds according to Formula 1 for use in methods of promoting wound healing, to formulations which incorporate these compounds and to a method of treating wounds using such compounds and formulations: wherein R 1 and R 2 may be the same or different and are selected from the group consisting of hydrogen (H) and a physiologically hydrolyzable chemical group consisting of alkylcarbonyl, alkenylcarbonyl arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, heteroaryloxycarbonyl, alkylether, alkenylether, arylether, and heteroarylether groups wherein the alkyl moiety consists of unsubstituted or substituted, straight-chain or branched-chain and cyclic alkyl groups having 2-22 carbon atoms, wherein the alkenyl moiety consists of unsubstituted and substituted, straight-chain or branched-chain and cyclic alkenyl groups having 2-22 carbon atoms, wherein the aryl moiety consists of unsubstituted and substituted phenyl, and phenalkyl groups wherein the alkyl moiety contains 1-3 carbon atoms and the phenyl moiety is unsubstituted or substituted, and the heteroaryl moiety is an aromatic 5- or 6-membered heterocyclic ring containing one or two heteroatoms selected from the group consisting of nitrogen, oxygen, and sulphur.La présente invention concerne le traitement de plaies. Plus particulièrement, elle concerne des composés selon la formule (1) en vue d'une utilisation dans des procédés d'amélioration de la cicatrisation des plaies, des formulations qui incorporent ces composés et d'un procédé de traitement de plaies utilisant lesdits composés et lesdites formulations : dans lesquels R1 et R2 peuvent être identiques ou différents et sont choisis dans le groupe consistant en hydrogène (H) et un groupe chimique physiologiquement hydrolysable consistant en les groupes alkyle, alkyl carbonyle, alcénylcarbonyle, arylcarbonyle, hétéroarylcarbonyle, alkoxycarbonyle, arylox
